In agreement with this study, Ohta et al. demonstrated that although 10 μM troglitazone can induce DNA fragmentation in BHP18-21, a thyroid papillary carcinoma cell line, it was not able to change the expression level of bcl-2 and bax genes. The gene discussed is BAX; the disease is thyroid gland papillary carcinoma.